Cartesian Growth Corporation II Faces Financial Struggles Amid Imminent Nasdaq Delisting

Company Overview
Cartesian Growth Corporation II (NASDAQ: RENEW) is a blank check company formed to effect a business combination. Unfortunately, the company has faced significant challenges in finalizing its initial business acquisition, leading to notable impacts on its financial statements.

Income Statement Highlights
For the three months ended March 31, 2025:

• Net Income: $559,864
• Operating Costs: $195,387
• Interest Income (Trust Account): $672,811
• Change in Fair Value of Warrant Liabilities: $77,864
• Change in Fair Value of Convertible Promissory Notes: $4,576

Income Statement Analysis
Positive Aspects:

• The company reported a net income of $559,864, though it is significantly down from the previous year’s figure of $2,534,872.
• Interest income from cash and marketable securities held in the Trust Account was healthy at $672,811.

Negative Aspects:

• Operating costs rose slightly compared to the previous year's period which was $223,183.
• Overall, net income has fallen sharply from $2,534,872 during the comparable period in 2024, indicating potential challenges in effectively managing expenses amid ongoing operational limitations.

Balance Sheet Highlights (as of March 31, 2025)

• Total Assets: $85,973,495
• Total Liabilities: $21,109,500
• Working Capital Deficit: $3,682,958
• Cash in Operating Account: $81,252
• Cash and Marketable Securities Held in Trust Account: $85,688,408

Key Points

• The company had $3,682,958 in working capital deficit as of March 31, 2025.
• The cash held outside the Trust Account decreased to $81,252, indicating limited liquid resources for new initiatives.
• As of May 6, 2025, the company anticipates delisting from Nasdaq due to failing to complete its initial business combination within the prescribed 36-month period post-IPO.

In conclusion, Cartesian Growth Corporation II (NASDAQ: RENEW) is in a precarious financial position. While it still has significant assets held in trust, the ongoing operational struggles, increasing cost base, and imminent delisting from Nasdaq add substantial risks to its future.